Recombinant Archimandrita tessellata Periviscerokinin-1

What is Periviscerokinin-1 and how was it first identified in Archimandrita tessellata?

Periviscerokinin-1 belongs to the periviscerokinin/CAP2b peptide family first identified in insects. While specific information about Archimandrita tessellata periviscerokinin-1 is limited in current literature, related peptides have been identified using a combination of immunocytochemistry and mass spectrometric analysis of single cells. For example, a related peptide (Ixori-PVK, PALIPFPRV-NH2) was identified in ticks showing high sequence homology with insect periviscerokinin/CAP2b peptides . The methodological approach for identification typically involves:

• Isolation of the neurohormone from single cells

• Mass spectrometric analysis using MALDI-TOF/TOF techniques

• De novo sequencing of the peptide structure

• Comparative sequence analysis with known peptides

Similar methodologies would likely be employed for identifying periviscerokinin-1 in Archimandrita tessellata specimens.

What is the primary physiological function of Periviscerokinin-1 in Archimandrita tessellata?

Based on homologous peptides in other arthropods, Periviscerokinin-1 likely plays a critical role in water balance regulation and diuretic processes . Cockroaches like Archimandrita tessellata require precise osmoregulation mechanisms, particularly during feeding and molting stages2. The peptide may function as a neurohormone released into the hemolymph to regulate:

• Water reabsorption in Malpighian tubules

• Ion transport across epithelial membranes

• Gut motility and digestive processes

• Metabolic responses to feeding

Research investigating the specific functions often employs immunohistochemistry to locate receptors, coupled with physiological assays measuring water and ion transport in isolated tissues.

What is the amino acid sequence of Archimandrita tessellata Periviscerokinin-1 and how does it compare to homologous peptides?

While the exact sequence for Archimandrita tessellata Periviscerokinin-1 is not specified in the provided information, related peptides like Ixori-PVK (PALIPFPRV-NH2) from ticks have been fully characterized . Periviscerokinin peptides typically share the C-terminal sequence motif -PRV-NH₂, which is critical for receptor binding and biological activity.

The following table summarizes comparative sequences of periviscerokinin-like peptides across species:

High energy collision-induced dissociation is particularly useful for distinguishing between leucine (Leu) and isoleucine (Ile) residues in these peptides, which have identical masses but different fragmentation patterns .

What are the optimal mass spectrometry parameters for characterizing recombinant Periviscerokinin-1?

For optimal mass spectrometric characterization of recombinant Periviscerokinin-1, researchers should consider the following parameters:

MALDI-TOF/TOF Analysis Protocol:

• Matrix selection: α-cyano-4-hydroxycinnamic acid (CHCA) is typically preferred for peptides under 5 kDa

• Laser energy: 25-30% above ionization threshold to maximize fragmentation while minimizing noise

• Collision energy: 1-2 keV for high-energy collision-induced dissociation to distinguish Leu/Ile residues

• Mass analyzer settings: Reflectron mode for improved resolution of fragment ions

• Calibration: External calibration using peptide standards in the 500-2500 Da range

Researchers should prepare recombinant peptide samples at concentrations of 10-100 pmol/μL in 0.1% TFA for optimal signal-to-noise ratio. Post-translational modifications, particularly C-terminal amidation critical for periviscerokinin activity, should be verified through MS/MS fragmentation patterns.

How can researchers efficiently express and purify recombinant Archimandrita tessellata Periviscerokinin-1?

While specific protocols for recombinant Periviscerokinin-1 from Archimandrita tessellata are not detailed in the search results, based on established practices for similar neuropeptides, researchers might adopt the following strategy:

Expression System Selection:

• E. coli BL21(DE3) with pET vectors for high-yield expression

• Baculovirus-infected insect cells (Sf9 or High Five) for proper post-translational modifications

• Yeast systems (P. pastoris) for secreted expression with correct disulfide bond formation

Purification Strategy:

• Initial capture: Immobilized metal affinity chromatography (IMAC) using 6×His-tag

• Intermediate purification: Ion exchange chromatography based on peptide's pI

• Polishing: Reversed-phase HPLC for high purity

• Tag removal: TEV or Factor Xa protease cleavage followed by second IMAC

• Quality control: Mass spectrometry to confirm correct sequence and post-translational modifications

Expression yields of 5-20 mg/L are typically achievable, with final purity >95% required for functional assays and structural studies.

What methodological approaches best assess the physiological activity of recombinant Periviscerokinin-1?

Assessment of recombinant Periviscerokinin-1 activity requires multiple complementary approaches:

In Vitro Functional Assays:

• Receptor binding assays using isolated tissues from Archimandrita tessellata

• Fluid secretion measurements in isolated Malpighian tubules

• Calcium mobilization in cells expressing cloned receptors

• Electrophysiological recordings from target tissues

In Vivo Assessment:

• Injection studies measuring physiological parameters

• RNAi-mediated receptor knockdown to confirm specificity

• Developmental and reproductive impact analysis

Researchers should establish dose-response relationships (EC₅₀ values) and compare activity with native peptide preparations. Typical EC₅₀ values for periviscerokinin peptides in receptor activation assays range from 1-100 nM, with recombinant peptides frequently showing slightly lower potency than native isolates due to subtle differences in post-translational modifications.

How does Periviscerokinin-1 from Archimandrita tessellata compare functionally to homologous peptides in other cockroach species?

The functional comparison of periviscerokinin peptides across cockroach species reveals both conserved and species-specific adaptations:

While direct comparison data for Archimandrita tessellata is not provided in the search results, existing research on related species suggests that periviscerokinin peptides typically maintain core functions in water regulation while evolving species-specific potency and secondary functions2. Cockroaches in the Blaberidae family (which includes Archimandrita tessellata) share similar physiological systems for water regulation, suggesting functional conservation of these peptides2.

Comparative studies would typically address:

• Receptor binding affinity and specificity

• Dose-response relationships in target tissues

• Temporal expression patterns during development

• Regulation in response to environmental stressors

Single-cell mass spectrometry techniques have proven valuable for comparing peptide expression patterns across species, enabling researchers to correlate structural variations with functional differences .

What are the experimental challenges in studying the structure-activity relationship of Periviscerokinin-1?

Researchers face several key challenges when investigating structure-activity relationships:

• Sequence verification challenges:

  • Distinguishing between leucine and isoleucine residues requires high-energy collision-induced dissociation

  • Confirmation of C-terminal amidation status requires specialized MS fragmentation techniques

• Receptor characterization difficulties:

  • Multiple receptor subtypes may exist with overlapping specificity

  • Tissue-specific receptor expression patterns require microscale analysis techniques

• Activity assessment limitations:

  • In vitro assays may not fully recapitulate in vivo activity

  • Concentration-dependent effects may vary between tissues

• Analytical constraints:

  • Sample preparation from single cells requires specialized techniques to avoid degradation

  • Native peptide quantities are typically in the femtomole to picomole range, necessitating highly sensitive detection methods

To address these challenges, researchers typically employ alanine-scanning mutagenesis to systematically replace individual amino acids and assess the impact on activity, combined with computational modeling of peptide-receptor interactions.

How can single-cell mass spectrometry improve our understanding of Periviscerokinin-1 expression and function?

Single-cell mass spectrometry represents a significant methodological advancement for neuropeptide research:

The application of MALDI-TOF/TOF mass spectrometry to single cells has revolutionized neuropeptide research by enabling:

• Spatial mapping of peptide expression:

  • Identification of specific neurosecretory cells producing Periviscerokinin-1

  • Correlation of peptide expression with anatomical structures

• Temporal expression analysis:

  • Monitoring changes in peptide levels during different physiological states

  • Detecting developmental regulation of peptide expression

• Co-expression pattern identification:

  • Determining which peptides are co-released from the same cells

  • Understanding peptide processing from precursors to mature forms

• Direct de novo sequencing:

  • Complete peptide sequence determination from limited sample material

  • Detection of post-translational modifications and processing events

This approach has already proven successful for identifying the first peptidergic neurohormone from ticks using single cell preparations, establishing a methodological framework that can be applied to Archimandrita tessellata research .

What potential applications exist for recombinant Periviscerokinin-1 in pest management research?

Recombinant Periviscerokinin-1 offers several promising avenues for pest management research:

• Target validation studies:

  • Confirmation of periviscerokinin receptors as druggable targets

  • Assessment of physiological consequences of receptor modulation

• Bioinsecticide development:

  • Design of peptide mimetics that disrupt water balance regulation

  • Development of delivery systems for peptide-based insecticides

• Resistance management:

  • Targeting evolutionary conserved physiological pathways to minimize resistance development

  • Identification of species-specific receptor variants for selective targeting

• Ecological impact assessment:

  • Determination of species specificity to minimize off-target effects

  • Understanding of environmental persistence and biodegradation pathways

Research on related periviscerokinin peptides has already demonstrated that disruption of these signaling pathways can significantly impact insect survival, weight, and reproductive output , suggesting similar potential for Archimandrita tessellata periviscerokinin-based interventions.

What techniques can resolve contradictory findings when studying Periviscerokinin-1 activity across different experimental systems?

When faced with contradictory experimental results, researchers should implement the following approaches:

• Standardization of experimental conditions:

  • Define precise developmental stages for comparison

  • Control environmental variables (temperature, humidity, photoperiod)

  • Establish consistent sample preparation protocols

• Multi-technique validation:

  • Complement mass spectrometry with immunochemical methods

  • Verify receptor activity through both binding and functional assays

  • Correlate in vitro findings with in vivo physiological measurements

• Genetic approaches:

  • Generate receptor knockout/knockdown models

  • Use CRISPR-Cas9 to create tagged endogenous proteins

  • Employ tissue-specific gene expression techniques

• Systematic meta-analysis:

  • Apply statistical methods to integrate results across studies

  • Account for methodological differences in data interpretation

  • Identify patterns in seemingly contradictory results

A combinatorial approach using both recombinant peptides and native isolates, tested across multiple biological assays, provides the most robust resolution of contradictory findings.

How might advances in imaging mass spectrometry contribute to Periviscerokinin-1 research?

Imaging mass spectrometry (IMS) techniques offer transformative capabilities for neuropeptide research:

Recent developments in imaging mass spectrometry provide unprecedented spatial information about peptide distribution and processing:

• Anatomical mapping capabilities:

  • Direct visualization of periviscerokinin distribution in tissues without antibodies

  • Correlation of peptide localization with specific cellular structures

  • Detection of peptide processing intermediates in their native locations

• Temporal dynamics assessment:

  • Monitoring changes in peptide distribution during development

  • Capturing rapid signaling events in response to physiological challenges

  • Tracking peptide metabolism and degradation pathways

• Multi-peptide co-localization:

  • Simultaneous mapping of multiple neuropeptides in the same tissue section

  • Discovery of previously unknown peptide co-expression patterns

  • Identification of processing enzyme distribution

• Technical considerations:

  • Spatial resolution now approaching cellular dimensions (10-50 μm)

  • Mass accuracy sufficient for peptide identification without chromatographic separation

  • Sample preparation protocols that preserve both spatial information and peptide integrity

These advanced techniques have already demonstrated value in profiling neuropeptides at both organ and cellular domains, providing insights impossible with traditional biochemical methods .

What are the most pressing research questions regarding Archimandrita tessellata Periviscerokinin-1 that remain unanswered?

Despite advances in neuropeptide research, several critical questions remain regarding Archimandrita tessellata Periviscerokinin-1:

• Structural characterization gaps:

  • Complete sequence determination including post-translational modifications

  • Three-dimensional structure in solution and receptor-bound states

  • Processing pathway from prepropeptide to mature form

• Physiological function questions:

  • Precise cellular targets and receptor subtypes

  • Integration with other neuroendocrine signaling pathways

  • Evolutionary significance of species-specific sequence variations

• Methodological challenges:

  • Development of specific antibodies for immunohistochemistry

  • Establishment of receptor expression systems for high-throughput screening

  • Creation of genetic tools for in vivo manipulation in Archimandrita tessellata

• Comparative aspects:

  • Comprehensive comparison with periviscerokinin peptides across arthropod taxa

  • Correlation of sequence variations with habitat adaptations

  • Identification of conserved functional motifs versus variable regions

Addressing these questions will require interdisciplinary approaches combining molecular biology, biochemistry, systems physiology, and computational modeling.

What emerging technologies might advance Periviscerokinin-1 research beyond current methodological limitations?

Several cutting-edge technologies show promise for overcoming current research limitations:

• Advanced mass spectrometry applications:

  • Ion mobility MS for improved separation of structural isomers

  • Ambient ionization techniques for real-time peptide monitoring

  • Ultra-high resolution MS for improved sequence coverage from limited samples

• Single-cell transcriptomics integration:

  • Correlation of neuropeptide expression with transcriptional profiles

  • Identification of co-regulated gene networks

  • Discovery of novel processing enzymes and receptor variants

• Cryo-electron microscopy:

  • Structural determination of peptide-receptor complexes

  • Visualization of conformational changes upon binding

  • Mapping of interaction surfaces at atomic resolution

• Computational approaches:

  • Molecular dynamics simulations of peptide-receptor interactions

  • Machine learning algorithms for predicting bioactive conformations

  • Systems biology models integrating multiple signaling pathways

• Microfluidic organ-on-chip technologies:

  • Recreation of physiological microenvironments for functional testing

  • Real-time monitoring of cellular responses to peptide exposure

  • High-throughput screening of peptide analogs and antagonists